Cell Cycle-Dependent Mobility of Cdc45 Determined in vivo by Fluorescence Correlation Spectroscopy by Broderick, Ronan et al.
Cell Cycle-Dependent Mobility of Cdc45 Determined in
vivo by Fluorescence Correlation Spectroscopy
Ronan Broderick
1., Sivaramakrishnan Ramadurai
1., Katalin To ´th
3, Denisio M. Togashi
2, Alan G. Ryder
2,
Jo ¨rg Langowski
3, Heinz Peter Nasheuer
1*
1Systems Biology Ireland and Centre for Chromosome Biology, School of Natural Sciences, National University of Ireland Galway, Galway, Ireland, 2Nanoscale
Biophotonics Laboratory, School of Chemistry, National University of Ireland Galway, Galway, Ireland, 3Biophysics of Macromolecules, German Cancer Research Center
(DKFZ), Heidelberg, Germany
Abstract
Eukaryotic DNA replication is a dynamic process requiring the co-operation of specific replication proteins. We measured
the mobility of eGFP-Cdc45 by Fluorescence Correlation Spectroscopy (FCS) in vivo in asynchronous cells and in cells
synchronized at the G1/S transition and during S phase. Our data show that eGFP-Cdc45 mobility is faster in G1/S transition
compared to S phase suggesting that Cdc45 is part of larger protein complex formed in S phase. Furthermore, the size of
complexes containing Cdc45 was estimated in asynchronous, G1/S and S phase-synchronized cells using gel filtration
chromatography; these findings complemented the in vivo FCS data. Analysis of the mobility of eGFP-Cdc45 and the size of
complexes containing Cdc45 and eGFP-Cdc45 after UVC-mediated DNA damage revealed no significant changes in diffusion
rates and complex sizes using FCS and gel filtration chromatography analyses. This suggests that after UV-damage, Cdc45 is
still present in a large multi-protein complex and that its mobility within living cells is consistently similar following UVC-
mediated DNA damage.
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Introduction
Duplication of chromosomal DNA is an essential process for
both normal cell division and to maintain stability of the genome
[1]. Replication of damaged DNA or errors in DNA replication
can lead to genetic mutation, with accumulated mutations leading
to diseases such as cancer [1]. In human cells, accurate duplication
of the genome is carried out by the ‘‘replisome progression
complex’’ (RPC), a large multi-subunit complex consisting of
replication proteins. These proteins work in concert at different
stages of the cell cycle to facilitate DNA replication [2,3,4,5,6,7].
Eukaryotic DNA replication begins with the binding of the multi-
subunit origin recognition complex (ORC) to the origins of
replication at the early G1 phase of the cell cycle [8,9]. This allows
the binding of additional proteins such as Cdc6 (cell division cycle
protein 6) and Cdt1 (Cdc10-dependent target) to ORC mediating
the loading of the Mcm2–7 (mini-chromosome maintenance)
complex to chromatin, forming the pre-replicative complex
(preRC) [8,9]. Activation of the preRC is mediated by CDKs
(cyclin-dependent kinases) and DDK (Dbf4-dependent kinase) to
allow the binding of Cdc45 and the GINS (go-ichi-ni-san (five-one-
two-three)) complex to the Mcm2–7 [8,9,10]. This activation of
the helicase function of Mcm2–7 allows the formation of a larger
multi-subunit protein machinery required for the elongation phase
of DNA replication [10,11] and of single-stranded DNA, which is
coated by RPA (replication protein A). DNA polymerase a-
primase (Pol-prim) synthesizes the first RNA primer for DNA
replication in the origin of replication, which is elongated by its
DNA polymerase activity. The RNA–DNA is recognized by RFC
(replication factor C), which loads PCNA (proliferating-cell
nuclear antigen) [8,9]. RFC and PCNA, together with RPA,
allow a polymerase switch from Pol-prim to Pol (DNA polymerase)
e or d, synthesizing the bulk DNA synthesis on the leading strand
and lagging strand, respectively [8,9].
Cdc45 protein has a key function in the initiation and
elongation phases of DNA replication [12] and recent data
indicated that Cdc45 is part of the CMG (Cdc45 Mcm2–7 GINS)
complex formed at the onset of S phase, progressing to a larger
RPC complex present at the elongation phase of DNA replication
[13]. Protein-protein interaction studies showed that human
Cdc45 interacts with Mcm5, Mcm7 and members of the GINS
complex as well as with Pols d and e in S phase cells [4]. The
current model suggests that in the RPC, Cdc45 forms a molecular
bridge between the helicase and DNA polymerase components of
the complex [7]. Cdc45 is also the target of a Chk1-mediated
intra-S-phase checkpoint [14].
Changes in the overall size of protein complexes containing
Cdc45 after activation of the intra-S-phase checkpoint have not
been examined and the question remains whether Cdc45 remains
as part of the RPC after activation of this checkpoint. Biochemical
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phases of DNA replication, but no in vivo data exists to elucidate
how Cdc45 is regulated inside cells as part of a multi-protein
complex [7]. To shed light on this function, we used Fluorescence
Correlation Spectroscopy (FCS) to examine the dynamics of
Cdc45 in living cells. FCS is a proven technique to measure
mobility of fluorescent molecules in vivo by analyzing the temporal
fluorescence fluctuations arising from molecules diffusing through
a femto-liter detection volume [15,16,17,18,19,20,21,22]. The
small detection volume may be obtained by the use of confocal
optics [23]. Typical concentrations of fluorescently tagged
molecules in FCS are in the nanomolar range, corresponding to
one or a few molecules simultaneously present in the observation
volume. These low intracellular protein concentrations pose a limit
for in vivo FCS measurements, as does the heterogeneity of the
cellular environment e.g., movement of organelles and of the
entire cell [20]. Furthermore, the autofluorescent protein tag must
exhibit a high photostability (such as eGFP), to avoid photo-
bleaching on the time scale of the measurement. Recently, we used
FCS to study dynamics of RPA in living cells [24]. Here, we
measured the mobility of eGFP-Cdc45 by FCS in vivo in
asynchronous cells and in cells synchronized at the G1/S
transition and during S phase. Our data show that eGFP-Cdc45
moves faster at the G1/S transition than during S phase.
Furthermore, the size of protein complexes containing endogenous
Cdc45 and eGFP-Cdc45 was estimated for the same cell cycle
stages in vitro by lysis in a low stringency buffer and gel-filtration
chromatography. These data show that eGFP-Cdc45 is part of a
multi-protein complex at the G1/S transition and of a very large
complex in S phase, which complements the FCS studies obtained
in vivo. Furthermore, the mobility of eGFP-Cdc45 and the size of
complexes containing Cdc45 and eGFP-Cdc45 were studied,
following UVC-mediated DNA damage using FCS and gel-
filtration chromatography. Surprisingly, both techniques did not
reveal significant changes in the mobility and complex sizes. This
suggests that after UV-damage Cdc45 is still present in large multi-
protein complexes.
Results
Generation of HeLa S3 cells stably expressing eGFP-
Cdc45
HeLa S3 cells stably expressing N-terminally tagged eGFP-
Cdc45 were generated to analyse Cdc45 in living cells (Figure 1a).
This cell line was generated by transfection of a plasmid coding for
eGFP-Cdc45 fusion protein under the control of the CMV
promoter followed by selection of G418-resistant cells. G418-
resistant cells were seeded in culture at a low density to isolate
single clones. Clones were selected, expanded and screened for
expression of eGFP-Cdc45 by western blotting. Quantitative
western blotting showed that eGFP-Cdc45 is expressed at 25% of
endogenous untagged Cdc45 in these cells (Figure 1b). In this
analysis the signal for eGFP-Cdc45 was compared to the
endogenous Cdc45 signal from the same blot. The latter was
arbritarily set to 100%. Since this low level of expression caused
problems to detect eGFP-Cdc45 by fluorescence microscopy,
eGFP-Cdc45 was also transiently expressed to the same level as
the endogenous protein. In this case we observed nucleoplasmic
localisation, consistent with earlier immunofluorescence studies
using an antibody specific for Cdc45 [4]. In addition, the co-
immunoprecipitation of eGFP-Cdc45 with a known interacting
protein, in this case Mcm7 [4,14], was carried out and verified by
western blotting (Figure 1c). This indicates that the eGFP-Cdc45
fusion protein interacts with essential components of the DNA
replication machinery.
Chromatin association of Cdc45 in the cell cycle and
UVC-mediated DNA damage
To verify our method, we tested whether chromatin association
of Cdc45 correlated with published data. Chromatin association of
Cdc45 as well as Mcm5, Mcm7, p125 and p261 of Pol d and e,
respectively, were analysed through the cell cycle (Figure 2a). Low
levels of Cdc45 associated with chromatin at the G1/S transition
whereas Cdc45 maximally bound to chromatin 6 h after the
release from the thymidine arrest (Figure 2a left panel) when
nearly all cells were in S phase of the cell cycle as determined by
Figure 1. HeLa S3 cells stably expressing eGFP-Cdc45. Panel a, schematic diagram of eGFP-Cdc45 protein encoded by Cdc45L ORF cloned into
pIC113gw vector. Panel b, total cell extract HeLaS3 cells (-ve) and Hela S3 cells stably expressing eGFP-Cdc45 (eGFP-Cdc45) normalized for protein
content and analysed by western blotting using antibodies raised against Cdc45 and b-Actin, which serves as a loading control. Panel c, western blot
analysis of immunoprecipitation of eGFP-Cdc45 using GFP-Trap IP from HeLa S3 cells transiently expressing eGFP-Cdc45. Verification of purification of
eGFP-Cdc45 and co-immunoprecipitation of Mcm7 was carried out using antibodies raised against Mcm7 and Cdc45. Input (L), unbound (FT), mock IP
(-ve) and IP from cells expressing eGFP-Cdc45 (eGFP) indicate yield of the IP and co-immunoprecipiation. Antibody light chain acts as a loading
control.
doi:10.1371/journal.pone.0035537.g001
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association with chromatin were minimal 12 h after release from
thymidine block when most cells were in G2 or M phase.
Chromatin association of the Mcm2–7 proteins was already very
high at the G1/S transition and remained persistently high
throughout S phase, whereas association of replicative DNA
polymerases was maximal during S phase.
In addition, chromatin association of Cdc45 was analysed
following a sub-lethal dose of UVC (Figure 2b). Two hours after
UV treatment, chromatin association of Cdc45 was reduced to
about 35% of the level of untreated cells, with recovery to normal
levels by 5 h post-treatment, as determined by quantitative
western blotting. The level of asynchronously growing cells was
arbritrarly set to 100%. Here, Cdc45 has similar chromatin
dissociation kinetics when compared to previous data obtained
using a low dose of the carcinogen BPDE, which induced a Chk1-
dependent dissociation of Cdc45 from the chromatin [14].
Changes of the diffusion coefficient of eGFP-Cdc45 in
HeLa cells during the cell cycle and after UV-mediated
DNA damage
The mobility and complex formation of eGFP-Cdc45 during
the cell cycle and after UV damage was also studied by FCS in
HeLa S3 cells stably expressing eGFP-Cdc45. Fluorescence
autocorrelation functions (ACFs) were fitted with a free or
anomalous diffusion model with a one- or two-component fit.
For the single-component free diffusion model, residuals (quality of
3-dimensional diffusion model fit to experimental data) show a
systematic deviation from the fit (Figure S1). The single-
component anomalous diffusion model provides a good residual
fit with an anomaly parameter a,0.760.1 (standard deviation),
however the diffusion time and the calculated diffusion coefficient
obtained with this model show a large standard deviation (Figure
S2 and Table S1), which is difficult to interpret in our model
system. Similarly, a two-component anomalous diffusion model
gave a good residual fit, but the anomaly parameter a showed
large standard deviations with a being around 1, which
corresponds to free diffusion [16] (Figure S3 and Table S2).
The large deviations in the anomaly parameter a are most likely
due to the noise on the ACF and led us to use a two component
free diffusion model which gave a very good fit with residuals close
to zero (Figure 3, lower panel). The intercellular diffusion
coefficient of eGFP and eGFP-Cdc45 analysed with the two-
component free diffusion model are summarized in Table 1. The
fractions r1 and r2 of the slow and the fast component, were about
40% and 60%, respectively, and remained similar throughout the
cell cycle and after UVC treatment. The fast component with the
diffusion coefficient (D2) was observed in eGFP transfected and
eGFP-Cdc45 stably expressing HeLa S3 cells, but not in
untransfected HeLa S3 cells. The diffusion times of the fast
component were in the range of 30–120 ms, which is in the range
of the known non-diffusive component of the ACF due to
protonation/deprotonation kinetics of eGFP [25]. The diffusion
coefficients D2 of the fast component were at least one order of
magnitude larger than the D1 values of the slow component. The
ratios of the diffusion coefficients of the slow to those of fast
component were constant throughout the cell cycle, therefore, we
will focus on the slow component for further discussion and
interpretation. Hereafter the diffusion coefficient of the slow
component will be called as D. We determined the in vivo diffusion
coefficient D of eGFP to be 3464 mm
2 s
21, similar to values found
by other labs [18,20,26,27]. The rather large variations among
reported values, including our own published values, are most
probably due to variations in cell lines, growth conditions, and
other biological variations.
The FCS measurements yielded a number of 20 to 40 (average:
31610) eGFP-Cdc45 molecules per femtolitre in these stably
eGFP-Cdc45-expressing HeLa S3 cells. With a nuclear volume of
about 500 to 600 fl for the HeLa S3 cells [24] this would yield
10,000 to 20,000 molecules of eGFP-Cdc45 per cell. Our
Figure 2. Association of Cdc45 with chromatin synchronized HeLa S3 cells and after DNA damage. Panel a, chromatin-associated lysate
from 1610
6 Hela S3 cells synchronized at various cell cycle stages by two consecutive thymidine block analysed by western blotting using antibodies
raised against Cdc45, Mcm7, Mcm5, Lamin B1, P261 and P125 of Pol e and d, respectively. The latter serves as a loading control. Asynchronous control
cells (Asn) or cells analysed at times ranging from 0 to 12 h following release from the second thymidine block (TdR 0 to TdR 12) were analysed in
parallel by FACS. Corresponding FACS profiles for relevant timepoints are also shown. Panel b, western blot of chromatin-associated Cdc45 following
UVC treatment. HeLa S3 cells treated with 5 J/m
2 UVC harvested at indicated timepoints post treatment with untreated cells (UT) acting as a control.
Chromatin-associated lysates normalized for protein content were analysed by western blotting using antibodies raised against Cdc45 and Lamin B1,
which serves as a loading control.
doi:10.1371/journal.pone.0035537.g002
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that the ratio of eGFP-Cdc45 to endogenous Cdc45 is approx-
imately 1 to 4 resulting in an estimate endogenous Cdc45 number
of 40,000 to 80,000 molecules per cell, which is in agreement with
previous estimated numbers of Cdc45 molecules per cell being
45,000 [28].
The diffusion coefficient D of eGFP-Cdc45 in asynchronous
cells shows a broad range, suggesting a large variation in the sizes
of the protein complexes containing eGFP-Cdc45 and that the
protein may function in a cell cycle dependent manner (Table 1).
In cells arrested at the G1/S transition, the diffusion coefficient D
of eGFP-Cdc45 is comparable to that in asynchronous cells, but
shows a smaller standard deviation (Table 1) suggesting less
variability in the sizes of eGFP-Cdc45-containing complexes. In S
phase, we determined D of eGFP-Cdc45 as 3.6 mm
2 s
21 with
standard deviations of 1.2 mm
2 s
21 in comparison to D of
9.762 mm
2 s
21 in G1/S transition phase. The molecular
brightness (CPSM) of eGFP-Cdc45 in S phase did not change
significantly compared to G1/S transition or to eGFP, excluding
higher oligomeric states of eGFP-Cdc45 in S phase (Figure S4)
[29]. Estimating sizes of protein complexes in living cells by FCS
remains very difficult due to variability in the intracellular
environment [18]. Nevertheless, we attempted to estimate the
relative molecular masses of the diffusing complexes from the
diffusion times as suggested by Brazda and colleagues [19],
assuming that the molecule has a spherical shape. To achieve this,
we compared the diffusion times of eGFP-Cdc45 and eGFP. The
molecular mass of the eGFP-Cdc45-complexes varied from 1
MDa in cells at the G1/S transition to 30 MDa in cells
synchronised during S phase of the cell cycle, while the monomeric
form of eGFP-Cdc45 weights approximately 95 kDa. After UVC-
mediated DNA damage, we observed no significant change in the
Figure 3. Auto-correlation curves of eGFP-Cdc45. The figure shows typical auto-correlation curves of eGFP-Cdc45 (%) in asynchronous HeLa S3
cells stably expressing eGFP-Cdc45. In the upper panel the solid black line corresponds to a two-component free diffusion model and in the lower
panel the gray line is the residual of the fit.
doi:10.1371/journal.pone.0035537.g003
Table 1. Diffusion coefficient of eGFP-Cdc45 at G1 to S phase transition and in S phase and after UV damage.
D1 ± SD (mm
2 s
21)r 1 D 2 ± SD (mm
2 s
21)r 2
eGFP 3464.0 0.5960.17 5006200 0.4160.17
eGFP-Cdc45 8.263.0 0.4160.17 159697 0.5960.17
eGFP-Cdc45 G1/S 9.762.0 0.4360.2 1756340 0.5760.2
eGFP-Cdc45 S phase 3.661.2 0.360.1 60637 0.760.1
eGFP-Cdc45 UVC 7.763.0 0.4960.2 116673 0.5160.19
Mean and standard deviations obtained from at least 15 cells.
doi:10.1371/journal.pone.0035537.t001
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data generated, we examined the sizes of complexes containing
eGFP-Cdc45 and endogenous Cdc45 at different cell cycle stages
and after UVC mediated DNA damage by gel filtration
chromatography.
Analysis of Cdc45 containing complexes by gel filtration
chromatography
Figure 4 shows examples of western blots of gel filtration
profiles. In these experiments we find a mixture of complex sizes,
with the most prevalent forms of Cdc45 being an apparently
monomeric population and a complex of the same size as the
thyroglobulin standard (669 kDa). In asynchronous cells the
monomeric Cdc45 is the prominent component, whereas in G1/
S synchronized cells we observed a shift of the Cdc45-containing
complexes towards the 700 kDa-sized complex (Figure 4, compare
panel a with b). In S phase-synchronized cells the size of the
Cdc45-containing protein complexes further increased, with the
largest complexes approaching 2 MDa (Figure 4a). In these gel
filtration experiments endogenous Cdc45 and eGFP-Cdc45
behave identically, taking into account that the monomeric
eGFP-Cdc45 is 27 kDa larger than monomeric endogenous
Cdc45. Interestingly, as observed in the FCS experiments
(Table 1), the complex formation of Cdc45 did not change after
treating asynchronous cells with UVC (Figure 4, compare panel a
with panel d).
For comparison, Mcm5 protein was analysed in the same
fractions of the gel filtration chromatogram as eGFP-Cdc45 in
asynchronous, G1/S transition- and S phase-synchronized cells. In
contrast to Cdc45 and Mcm5, the heterotrimeric RPA complex
shows approximately the same size in asynchronous and
synchronized cells in the gel filtration experiments as marked by
the second largest subunit of RPA, RPA32 (Figure 4 a to c, lowest
panels). Moreover, we found no changes in the overall size of
complexes containing Cdc45, Mcm5 and RPA32 after UVC
treatment, with phosphorylation of RPA32 observed in UVC
treated cells (Figure 4). These findings fit well with gel filtration
chromatography analyses of isolated CMG complexes from
Drosophila, with a size of the CMG complex roughly equal to
thyroglobulin (669 kDa) [10]. A separate study in budding yeast
estimated the size of RPC, with the CMG complex at its core, to
be about 2 MDa in S phase-synchronized extracts [13].
Discussion
To study the replication protein Cdc45 in vivo, we generated
HeLa S3 cells that stably expressed eGFP-Cdc45. The expression
levels of eGFP-Cdc45 in these cells were approximately 25% of
that of endogenous Cdc45. These low levels were particularly
suitable for FCS studies. Functionally, we showed that the eGFP-
Cdc45 fusion protein behaved identically to endogenous Cdc45 in
all biochemical assays [4]. Co-immunoprecipitation of Mcm7 with
eGFP-Cdc45 also validated its functionality. Interestingly, little
endogenous Cdc45 co-immunoprecipitated with eGFP-Cdc45,
suggesting that the eGFP-Cdc45-containing CMG and RPC
complexes contain only one molecule of Cdc45 per complex.
Transiently expressed eGFP-Cdc45 localized in the nucleoplasm
of HeLa S3 cells, similar to previously published localisation data
for Cdc45 [4]. Moreover, gel filtration chromatography showed
eGFP-Cdc45 in the same fractions as the endogenous protein,
suggesting that eGFP-Cdc45 can form the same complexes as
endogenous Cdc45.
The mobility of eGFP-Cdc45 was measured by FCS in
asynchronous HeLa S3 cells, G1/S transition-, S phase-synchro-
nized cells and in asynchronous cells following UVC-induced
DNA damage. The mobility of eGFP-Cdc45 was broadly
distributed in asynchronous HeLa S3 cells (Table 1) whereas its
mobility in S phase was reduced approximately 3 times compared
to cells at the G1/S transition (Table 1). Recent reports showed
that fluorescently tagged Cdc20 protein (,85 kDa) [22] and
PLK1 protein (,93 kDa) [20], which are similar in molecular
weight to eGFP-Cdc45, diffuse slowly in living cells. Monomeric
Cdc20 protein in living cells moved six times faster than the
multiprotein complexed form [22]. Upon mutation, the catalytic
activity of PLK1 protein decreased and its mobility increased,
reflecting a reduction in complex size [20]. Comparing the
diffusion rates of monomeric Cdc20 and eGFP-Cdc45 in living
cells suggests that eGFP-Cdc45 is putatively a part of multi-protein
complexes which may vary throughout the cell cycle. We
estimated the sizes of Cdc45-containing complexes to be about 1
MDa at the G1/S transition and 30 MDa in S phase using FCS
mobility data. To corroborate these results, we investigated the
sizes of complexes containing both endogenous and eGFP-tagged
Cdc45 by gel filtration chromatography. A low stringency lysis
buffer was used to solubilise proteins whilst keeping protein
complexes intact [30]. Size analysis of eGFP-Cdc45-containing
complexes by gel filtration chromatography gave results consistent
with similar analyses of isolated CMG complexes from Drosophila
of an estimated size of about 0.7 MDa [10]. The observation of a
larger complex during S phase, approaching 2 MDa, is consistent
with gel filtration analyses of proteins from budding yeast, where
isolated RPCs incorporating the CMG complex had an estimated
molecular mass of about 2 MDa [13]. The hypothesis that these
complexes observed in gel filtration chromatography assays are
indeed the CMG and RPC is supported by the observation that
Mcm5 protein is present in the same fractions as Cdc45 in the
G1/S transition and S phase-synchronized cells. The estimated
sizes of Cdc45-containing complexes at the G1/S transition were
slightly larger in living cells, as determined by FCS, than in the cell
extracts determined by gel filtration. A possible explanation is that
either proteins other than the Mcm2–7 and the GINS complexes
may associate with Cdc45 in vivo, that the complexes bind
transiently to immobile structures, or that the assumption needs to
be reconsidered that the Cdc45 protein complex has a spherical
shape. In the latter case, a different model for the molecular shape
might yield a molecular mass closer to the CMG core complex.
Even so, the gel filtration data correlate well with the FCS-
observed diffusion rates for eGFP-Cdc45, which confirms that the
in vitro biochemical assay reflects the dynamics of the actual in vivo
eGFP-Cdc45-containing complexes. As the cell progresses to S
phase, Cdc45 as part of the CMG complex forms an active RPC
complex [13]. Although both methods showed an increased size of
the S phase Cdc45 complexes compared to the G1/S complex, the
complex sizes determined by gel filtration and FCS, 2 MDa versus
30 MDa, clearly differ. This finding can be explained in different
ways. First, proteins including RPA might have been lost during
gel filtration and therefore the size of S phase Cdc45 complex in
living cells was underestimated in vitro. This is consistent with the
findings that the gel filtration carried out did not contain some
proteins which are part of RPC, such as RPA. However, the
protein diffusion in living cells is governed not only by the size of a
complex but also by interactions with stable scaffolds such as
chromatin [31,32]. Therefore, the slower mobility of Cdc45-
containing complex might be caused by the Cdc45-containing
transiently binding to DNA, chromatin, or other cellular structures
as previously discussed for RPA [24].
Analyses of chromatin association of replication proteins
presented here support the model that these proteins form
Mobility of Cdc45 in vivo
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data are consistent with reports showing the formation of the
CMG complex after the G1/S transition as chromatin association
of Mcm2–7 proteins is seen here as well as some chromatin
association of Cdc45 [11]. Association of Cdc45 to chromatin at
the G1/S transition with maximal association at S phase is
consistent with data demonstrating binding of Cdc45-GINS to
Mcm2–7 to form the CMG complex in a CDK- and DDK-
dependent manner. This would activate the helicase function of
the complex at the onset of S phase [10], coinciding with the
formation of the fully functional RPC. Maximal association of the
elongating DNA polymerases during S phase is consistent with
binding of these proteins to the active CMG as well as other
factors including Mcm10, Pol-prim, RFC, RPA, Claspin/Time-
less/Tipin, and Ctf4/And1 to create the RPC [4,9,13,33,34].
Following UVC treatment the affinity of Cdc45 for chromatin is
reduced between 0 and 2 h post treatment, with a recovery
between 2 h and 5 h post-treatment. In addition, phosphorylation
of RPA32 is observed in UV-treated samples, indicating the
activation of damage response. These data display similar kinetics
when compared with previously observed Chk1-dependent
reductions in chromatin-association of Cdc45 following treatment
of H1299 cells with BPDE [14]. However, FCS and gel filtration
chromatography showed no discernable effect on the overall
complex size of replisomes containing Cdc45 and on the
distribution of eGFP-Cdc45, Mcm5 or RPA32 after UV treatment
when compared to the asynchronous control. This lack of change
in size of eGFP-Cdc45-containing complexes following UV-
mediated DNA damage suggests that intact RPCs containing
Cdc45 are present following damage and might be reloaded as
such to start DNA replication again. These findings are consistent
with a model where RPCs containing Cdc45 undergo a
conformational change following UV-mediated damage, but still
contain Cdc45. Recent studies demonstrate that the CMG
complex can exist in a ‘‘locked’’ form and a more open ‘‘notched’’
form [35], where the gap observed between Cdc45 and the most
proximal Mcm2–7 proteins is larger in the ‘‘notched’’ conforma-
tion than in the ‘‘locked’’ form. A change in the overall structure
or conformation of the RPC complex containing Cdc45 following
fork stalling could explain the observed reduction in Cdc45’s
affinity for chromatin, its affinity for Mcm proteins, and the lack of
a significant change in complex size or diffusion rate for eGFP-
Cdc45 in living cells after UVC treatment (Table 1). Alternatively,
it may well be that the fraction of Cdc45 associated to chromatin
in asynchronous cells is too small to be detected by the FCS and
gel filtration chromatography assays.
We show that FCS can be used to characterize the mobility and
the dynamics of eGFP-Cdc45 in vivo in real time. The mobility
Figure 4. Analysis of the size distribution of Cdc45-containing protein complexes during the cell cycle and after UV damage.
Asynchronous (Asn) UVC-treated (+UVC, 5 J/m
2, 1 h post-treatment), G1/S transition or S phase synchronized HeLa S3 cells stably expressing eGFP-
Cdc45 were lysed and normalized for protein content and separated by gel filtration chromatography analysed by western blotting using antibodies
raised against Cdc45, Mcm5 and RPA 32. (panels a, b, c, and d, respectively). Theoretical molecular weight (kDa) and Stoke’s radius (A ˚) of protein
standards are overlayed. RPA32 acts as a marker for DNA damage response following UVC treatment. FACS analysis is provided for asynchronous
(Asn), G1/S transition and S phase synchronized cells (e) and asynchronous cells treated with 5 J/m
2, 1 h post-treatment (f).
doi:10.1371/journal.pone.0035537.g004
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containing complexes as analysed by FCS and gel-filtration
suggests that the association state of the protein is different at
the G1/S transition and during S phase. In contrast, we did not
observe a significant change in eGFP-Cdc45 mobility or complex
size after UVC-induced DNA damage, but did see a reduction in
Cdc45-chromatin association after damage; this suggests that large
Cdc45 complexes remain stable after removal from chromatin.
These observations merit further investigation by biochemical
methods and FCS.
Materials and Methods
Cell Culture
HeLa S3 cells (ATCC CCL2.2) [4] were cultured in Dulbecco’s
modified Eagle’s medium (Sigma) supplemented with 10% foetal
calf serum (Sigma), 100 units/ml penicillin (Lonza) and strepto-
mycin (Lonza). Cells stably expressing eGFP-Cdc45 were selected
and cultured in media supplemented with 500 mg/ml G418
sulphate (Lonza). For FCS, HeLa S3 cells that which stably express
eGFP-Cdc45 were grown in eight-well chambered cover glass
slides (Nunc, Denmark), Dulbecco’s modified Eagle’s medium
(DMEM, GIBCO) without phenol red, with 10% Foetal calf
serum (Sigma), 1% L-glutamine (Sigma) at 37uC in a humidified
incubator containing 5% CO2.
Antibodies
Antibodies recognizing Cdc45 (C45-3G10-111) [4], p125 of Pol
d (PGD-5E1) [28] and RPA 32 (RBF-4E4) [36,37]. Anti-Mcm5
antibody was obtained from Prof R. Knippers [38]. Mcm7
antibody was obtained from Neomarkers (47DC141). Antibody
raised against b-Actin was obtained from Sigma (A5441).
Antibody raised against Lamin b1 was obtained from Abcam
(ab16048). P261 Pol e antibody was obtained from BD Biosciences
(#611238).
Generation of eGFP-Cdc45 plasmid constructs
The ORF of Cdc45 was cloned into the gateway entry vector
pENTR3C (Invitrogen) between the BamH1 and EcoRI restric-
tion sites. The ORF was then recombined into a gateway-adapted
eGFP vector based on the pIC113 backbone (pIC113gw, a
generous gift from Prof. K. Sullivan) using the LR Clonase II
enzyme kit (Invitrogen), as described by the manufacturer.
Fluorescence correlation spectroscopy
FCS measurements were carried out in laboratory-built set up
as described in [18]. In short, confocal laser scanning microscopy
(CLSM) was performed with a built in FCS module attached via
an X-Y galvanometer scanner to an inverted microscope
(Olympus IX70, Hamburg, Germany) with an UplanApo/IR 60
X water immersion objective lens (Numerical aperture: 1.2). For in
vivo imaging and FCS, HeLa S3 cells stably expressing eGFP-
Cdc45 were plated into eight-well chambered coverslips (Nunc,
Denmark) and measured at 37uC in a 5% CO2 humidified
atmosphere, in an incubator chamber surrounding the entire
microscope. An argon-krypton laser with a 488 nm laser created
the fluorescence excitation, and emissions were detected between
515 to 545 nm with avalanche photodiodes (APDs) (SPCM-AQR-
13, Perkin-Elmer, Wellesley, USA) after passage through appro-
priate dichroic mirrors and filters for spectral separation. Home-
made control software allowed us to choose points from confocal
fluorescence images of nuclei for FCS measurements. The signals
coming from the APDs were fed into an ALV-5000/E correlator
card (ALV Laser GmbH, Langen, Germany), which accumulated
the autocorrelation function in parallel for all time delays and in
real time.
Nuclei were imaged using CLSM and 5 random positions were
selected. Autocorrelation measurements of 5 runs of 10 seconds
each were performed on each measurement point. The laser
power was 6 mW; no significant change in count rate due to photo-
bleaching was observed. For each dataset, we measured at least 15
cells on different days. Data sets that showed unusual variation or
oscillation in the count rates were excluded from our analysis. The
setup was calibrated using 20 nM AlexaFluor 488 dye (Molecular
Probes) in water as described [18].
Data analysis
The autocorrelation curves of multiple runs at each individual
measured point were fitted by a non-linear fitting using the
QuickFit software employing the Marquardt-Levenberg algorithm
(http://www.dkfz.de/Macromol/quickfit/). The autocorrelation
curves of were fitted with a two diffusional component, triplet
correction and a term for eGFP blinking [16,19].
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The autocorrelation function with the term accounting for triplet
state formation and dark state formation due to protonation (i.e.
blinking) and the term accounting for diffusion are (Gdiff) were
considered when analysing the data [25]. N is the average number
of fluorescently or tagged molecules in the confocal volume, t is
the lag time. In the triplet term T denotes the equilibrium molar
fraction of flurophores in the triplet state and ttr is the triplet life
time [39]. The protonation mechanism [25] is characterized by
the molecular fraction Hc and the correlation time tc.
Two diffusion terms were assumed: a slow species with mole
fraction r1 and diffusion time t1, and fast species with mole fraction
r2=12r1 and diffusion time t2. S denotes the structure factor,
which depends on the focal volume and is given by S=Z0/w0,
where Z0 is the axial and w0 the lateral dimension of the confocal
volume. The anomaly parameter a corresponds to the mechanism
of diffusion; a=1 corresponds to free diffusion while a,1
corresponds to obstructed diffusion [16]. Anomalous diffusion
can result from transient binding or molecular crowding [40].
The diffusion time ti (i=1,2) is related to the diffusion
coefficient D by:
ti~ w0 ðÞ
2.
4D: ð4Þ
The lateral radius (w0) at 488 nm excitation was estimated from
the diffusion coefficient of Alexa Fluor 488 (20 nM in deionized
water). The calculated lateral radius was w0=(25065) nm, taking
D as 435 mm
2 s
21 at 22.5uC [41].
The change in apparent molecular mass of proteins was
calculated based on the Stokes-Einstein equation [19]. Assuming
the diffusing species as spheres,
(3)
(2)
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apparent
eGFP{Cdc45
 
MeGFP~ DeGFP=DeGFP{Cdc45 ðÞ
3
~ teGFP{Cdc45=teGFP ðÞ
3 ð5Þ
where MeGFP=27 kDa is the molecular mass of eGFP, D and t
correspond to the diffusion coefficient and diffusion time of eGFP-
Cdc45 and eGFP as indexed.
Cell synchronisation
HeLa S3 cells and eGFP-Cdc45-expressing HeLa S3 cells were
enriched in late G1 to early S phase by performing two
consecutive thymidine blocks as previously described [4]. In short,
cells were cultured for 24 h in media without thymidine before
addition of 5 mM thymidine for 16 h. Subsequently, cells were
washed 2 times with PBS and allowed to grow in DMEM without
thymidine for 12 h before a second treatment with 5 mM
thymidine for 16 h. After this incubation time, cells synchronized
at the G1/S transition were analysed using FCS. Cells were
washed with PBS, fresh media was added and 5 h later, FCS
measurements were carried out for S phase-synchronized cells.
Cell lysis and immunoblotting
Total cell lysates were prepared in RIPA buffer (1% Triton X-
100, 0.5% deoxycholate, 1% Sodium Dodecyl Sulphate (SDS) in
PBS, pH 7.4) supplemented with phosphatase inhibitor cocktail II
(Sigma) and ETDA-free protease inhibitor cocktail (Roche
Applied Sciences). Lysates for immunoprecipitation were prepared
in TGN buffer (50 mM Tris-HCl pH 7.5, 200 mM NaCl, 50 mM
sodium b-glycerophosphate, 50 mM Sodium Fluoride, 1%
Tween-20, 0.2% NP-40) supplemented with phosphatase inhibitor
cocktail II (Sigma) and ETDA free protease inhibitor cocktail
(Roche Applied Sciences). Briefly, cells were lysed for 20 min on
ice and centrifuged for 10 min at 13,0006ga t4 uC. Supernatant
fractions were collected and used as input for immunoprecipitation
experiments.
Lysates for gel filtration chromatography experiments were
prepared in 50 mM Tris-HCL pH 7.4, 250 mM NaCl, 5 mM
EGTA, 3 mM MgCl2 0.1% NP-40 supplemented with phospha-
tase inhibitor cocktail II (Sigma) and ETDA free protease inhibitor
cocktail (Roche Applied Sciences). Cells were lysed for 20 min on
ice before addition of Benzonase (Sigma, adjusted to 250 U/10
7
cells) and incubation at 25uC for 30 min to solubilise chromatin
associated proteins. Lysates were then clarified by centrifuging for
30 min at 100,0006 ga t4 uC. Supernatants were collected and
used as input for gel filtration chromatography.
Lysates, to analyse chromatin association of various proteins,
were prepared in a procedure adapted from Liu and colleagues
[14]. In brief, 1610
7 HeLa S3 cells were rinsed once in PBS and
scraped into a minimal volume of ice cold PBS. Cells were then
centrifuged at 10006g for 2 min and resuspended in 250 ml CSK
buffer (10 mM PIPES, pH 6.8, 100 mM NaCl, 300 mM sucrose,
3 mM MgCl2, 1 mM EGTA, 1 mM dithiothreitol, 0.1 mM ATP,
1m M N a 3VO4, 10 mM NaF, and 0.1% Triton X-100)
supplemented with EDTA free protease inhibitor cocktail (Roche
Applied Sciences) and incubated on ice for 4 min. Lysates were
then centrifuged at 10006g for 2 min, and the supernatant was
collected as the triton-soluble fraction. Triton-insoluble pellet was
washed once in 1 ml CSK buffer and resuspended in 100 ml CSK
buffer. RNase-free DNaseI (Applichem), adjusted to 250 U/10
7
cells was then added and lysates were incubated for 30 min at
25uC to release chromatin-associated proteins. Lysates were then
centrifuged at 4uC and 10,0006g for 10 min and the supernatant
fractions collected as chromatin-associated fractions.
Cell extracts were resolved by SDS-PAGE, transferred to PVDF
membrane and analysed by western blotting using antibodies
raised against specific proteins. Western blots were then probed
with horseradish peroxidase-conjugated secondary antibodies
(HRP, Jackson Immuno Research) and visualized using the ECL
or ECL Plus chemiluminescent solution (GE Healthcare).
Quantitative western blotting
For quantitative western blotting, images of western blots were
acquiredusing aLAS3000imagingsystem andsoftware(Fuji).Images
were analysed quantitatively using Multi Guage V2.2 software (Fuji)
to determine the relative signal intensities of distinct bands.
Immunoprecipitation
eGFP-Cdc45 was immunoprecipitated from cells using GFP-
TrapH (ChromoTek) and low adhesion tubes (Bioquote Limited).
Briefly, 2610
7 HeLa S3 cells were transfected with 20 mg plasmid
coding for eGFP-Cdc45 protein using Fugene/X-tremeGENE HP
transfection reagent (Roche Applied Sciences), harvested 24 h
post-transfection and lysed in TGN buffer. Protein A/G agarose
resin (Calbiochem) was washed three times in TGN buffer and
5 mg lysate was incubated with this resin for 30 min at 4uC to pre-
clear. 20 ml packed GFP-TrapH-A resin was washed three times in
TGN buffer and incubated with 5 mg pre-cleared lysate from cells
transfected with eGFP-Cdc45 plasmid or from mock-transfected
control cells. Lysates were incubated with the resin for 2 h at 4uC
and washed four times with 1 ml of TGN buffer. Bound proteins
were solubilised by boiling beads in 40 mlo f2 6 Laemmli buffer
and centrifugation at 5,0006 g for 5 min. Supernatant fractions
were collected and analysed by SDS-PAGE and western blotting.
Flow cytometry and FACS analysis
1610
6 HeLa S3 cells were trypsinized, washed in ice cold PBS
and resuspended in 1 ml PBS. Ice cold ethanol was added to a
final concentration of 75% to fix samples for flow cytometry.
Before FACS analysis samples were centrifuged at 15006 g, the
supernatant was removed, and the cell pellet was resuspended in
1 ml propidium iodide with RNAse solution (BD Biosciences) and
incubated overnight at 4uC. Flow cytometry was carried out using
a FACS CANTO flow cytometer (BD Biosciences) and flow
cytometry data was analysed using WinMDI software.
Gel filtration chromatography
Gel filtration of lysates was carried out using a Superdex 200 PC
3.2/30 column and an A ¨kta Ettan HPLC machine (Amersham
Biosciences) with a 50 ml injection loop. The column was
calibrated using a high molecular weight (HMW) gel filtration
calibration kit (28-4038-42 GE Healthcare) and 300 mg of lysate
prepared for gel filtration chromatography as described above was
then loaded onto the column. Fractions of 100 ml volume were
collected, snap frozen and lyophilised using a freeze dryer
(Labconco). Freeze-dried fractions were then resuspended in
20 ml1 6 Laemmli buffer, boiled for 5 min and analysed by
SDS-PAGE and western blotting.
Supporting Information
Figure S1 Autocorrelation function of eGFP-Cdc45 in
asynchronous HeLa S3 cells stably expressing eGFP-
Cdc45 fitted to one-component free diffusion model. (%)
corresponds to experimentally determined autocorrelation func-
tion. The solid black line is the diffusion model fit and the gray line
corresponds to the residual of the fit.
(DOC)
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asynchronous HeLa S3 cells stably expressing eGFP-
Cdc45 fitted to one-component anomalous diffusion
model. (%) corresponds to experimentally determined autocor-
relation function. The solid black line corresponds to the diffusion
model fit and the gray line corresponds to the residual of the fit.
(DOC)
Figure S3 Autocorrelation function of eGFP-Cdc45 in
asynchronous HeLa S3 cells stably expressing eGFP-Cdc45
fitted to a two-component anomalous diffusion model. (%)
corresponds to experimentally determined autocorrelation func-
tion. The solid black line corresponds to the diffusion model fit and
gray line corresponds to the residual of the fit.
(DOC)
Figure S4 Molecular brightness (CPSM) of eGFP which
was transiently expressed in HeLa S3 cells and from
HeLa S3 cells stably expressing eGFP-Cdc45 in different
cell cycle stages, in UV treated and Asynchronous cells.
Error bars correspond to standard deviation from at least 15 cells.
(DOC)
Table S1 Single-component anomalous diffusion model
fit to eGFP, eGFP-Cdc45 in different cell cycle stages and
UVC treatment.
(DOC)
Table S2 Two-component anomalous diffusion model
fit to eGFP, eGFP-Cdc45 in different cell cycle stages and
following UVC treatment.
(DOC)
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